Arena Pharma (ARNA) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts ARNA Hot Sheet
Price: $99.98 --0%
Financial Fact:
Loss from operations: -9.86M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Loss from operations: -9.86M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Arena Pharma (NASDAQ: ARNA) reported Q3 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $19 million versus the consensus estimate of $13.99 million.
For earnings history and earnings-related data on Arena Pharma (ARNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Madison Square Garden Sports Corp. (MSGS) Tops Q4 EPS by 62c
- CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
